Response to HDT
| . | Arm A HDM140/TBI (n = 140) . | Arm B HDM200 (n = 142) . | P . |
|---|---|---|---|
| CR (%) | 41 (29) | 49 (35) | .41 |
| VGPR (%) | 19 (14) | 29 (20) | .17 |
| CR + VGPR (%) | 60 (43) | 78 (55) | .06 |
| PR (%) | 65 (46) | 56 (39) | .28 |
| Stable or progressive disease (%) | 10 (7) | 8 (6) | .78 |
| Toxic death (%) | 5 (4) | 0 (0) | .07 |
| . | Arm A HDM140/TBI (n = 140) . | Arm B HDM200 (n = 142) . | P . |
|---|---|---|---|
| CR (%) | 41 (29) | 49 (35) | .41 |
| VGPR (%) | 19 (14) | 29 (20) | .17 |
| CR + VGPR (%) | 60 (43) | 78 (55) | .06 |
| PR (%) | 65 (46) | 56 (39) | .28 |
| Stable or progressive disease (%) | 10 (7) | 8 (6) | .78 |
| Toxic death (%) | 5 (4) | 0 (0) | .07 |